Phosphodiesterase IV inhibitors as therapy for eosinophil-induced lung injury in asthma

Environmental Health Perspectives

Volumn 102, Issue SUPPL. 10, 1994, Pages 79-84

  Torphy, T J ^a   Barnette, M S ^a   Hay, D W P ^a   Underwood, D C ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Airway hyperreactivity; Asthma; Cyclic AMP; Eosinophil; Epithelial injury; Epithelium; Phosphodiesterase; Phosphodiesterase inhibitors; Superoxide

Indexed keywords

ANTIASTHMATIC AGENT; CYCLIC AMP; PHORBOL MYRISTATE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; REACTIVE OXYGEN METABOLITE; ROLIPRAM; SIGUAZODAN; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; ZAPRINAST;

ANIMAL CELL; ASTHMA; CELL ADHESION; CONFERENCE PAPER; CYTOTOXICITY; ENDOTHELIUM CELL; EOSINOPHIL; GUINEA PIG; INFLAMMATORY CELL; LUNG INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; UMBILICAL VEIN;

ANIMALIA; CAVIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0028559807     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.94102s1079     Document Type: Conference Paper

References (0)